Healthcare (SH:603313) Xin Lang Cai Jing·2025-11-20 02:44Core Viewpoint - The stock price of Dream Lily has experienced fluctuations, with a recent decline of 3.09% and a total market capitalization of 5.01 billion yuan. The company has seen significant net outflows of capital, indicating potential investor concerns [1]. Group 1: Stock Performance - Dream Lily's stock price has increased by 31.04% year-to-date, but it has declined by 6.99% over the last five trading days and 9.39% over the last twenty days [2]. - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent net purchase of 37.19 million yuan on October 17 [2]. Group 2: Company Overview - Dream Lily, established on May 30, 2003, and listed on October 13, 2016, specializes in home products aimed at enhancing deep sleep, including memory foam mattresses and pillows [2]. - The revenue composition includes memory foam mattresses (52.06%), sofas (13.12%), and other products [2]. Group 3: Financial Performance - As of September 30, 2025, Dream Lily reported a revenue of 6.756 billion yuan, reflecting a year-on-year growth of 10.29%, and a net profit of 161 million yuan, marking a significant increase of 205.18% [3]. - The company has distributed a total of 546 million yuan in dividends since its A-share listing, with 28.53 million yuan distributed over the last three years [4]. Group 4: Shareholder Information - As of September 30, 2025, the number of shareholders decreased to 24,100, with an average of 23,651 circulating shares per person [3]. - Notable changes in institutional holdings include a reduction in shares held by major funds, with new entries among the top ten shareholders [4].